Roger Adsett
CIK 1685904 · Chief Operating Officer · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$9.65M
Companies
3
Total Filings
49
Lifetime Open-Market Net
-$30.70M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 4 of 5
49 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-18 | INSM | Sell (S) | −3,416 | -$66.8K | EDGAR |
| 2022-05-13 | INSM | Grant (A) | +27,460 | $0 | EDGAR |
| 2022-03-10 | Landos Biopharma, Inc. (LABP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-13 | INSM | Sell (S) | −1,217 | -$29.9K | EDGAR |
| 2022-01-10 | INSM | Grant (A) | +17,735 | $0 | EDGAR |
| 2022-01-07 | INSM | Sell (S) | −4,827 | -$130.4K | EDGAR |
| 2021-05-18 | INSM | Tax (F) | −2,477 | -$65.0K | EDGAR |
| 2021-05-14 | INSM | Grant (A) | +14,172 | $0 | EDGAR |
| 2021-01-08 | INSM | Grant (A) | +11,019 | $0 | EDGAR |
| 2021-01-06 | INSM | Tax (F) | −5,188 | -$159.6K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.